WaveLight® Refractive Myopic Study

Refractive Error Clinical Trial

Official title:

A Prospective, Global, Multi-Center Study for the Evaluation of Outcomes on Subjects Undergoing Myopic Treatments Using the WaveLight® Refractive Suite

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01941498
• Other study ID #: A01353
• Status: Completed
• Phase: N/A
• First received: September 10, 2013
• Last updated: October 2, 2015
• Start date: September 2013
• Est. completion date: August 2014

Study information

• Verified date: October 2015
• Source: Alcon Research
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review BoardIreland: Research Ethics CommitteeGermany: Ethics Commission
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to evaluate outcomes of subjects undergoing myopic surgery using the WaveLight® Refractive Suite (Excimer EX500 and Femtosecond FS200 lasers).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 104
• Est. completion date: August 2014
• Est. primary completion date: January 2014
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Willing and able to understand and sign an informed consent form.

• Have refractive error (in both eyes) that requires refractive surgery.

• Willing to undergo LASIK surgery using the Wavelight® Refractive Suite.

• Myopia between 0.00 to -12.0 diopters pre-operatively.

• Astigmatism between 0.00 to +6.00 diopters pre-operatively.

• Willing and able to attend post-operative examinations per protocol schedule.

• Other protocol-defined inclusion criteria may apply.

Exclusion Criteria:

• Participation in a clinical study within the last 30 days.

• History of previous corneal surgery in either eye.

• Multifocal ablations in either eye.

• PRK or PTK surgery in either eye.

• Suffering from acute or recurring eye diseases in either eye, such as corneal ulcers, cataract, etc.

• Any ocular disease and/or condition that, in the Investigator's clinical judgment, may put subject at significant risk, compromise study results, or interfere significantly with subject's participation in the study.

• Unable to discontinue contact lens wear as specified in protocol.

• History of Herpes simplex or Herpes zoster keratitis.

• Active ocular rosacea.

• Lyme disease.

• History of dry eye that is unresponsive to treatment.

• Severe ocular allergies.

• Other medical conditions and use of medications as specified in protocol.

• Pregnant or planning to become pregnant during the study.

• Other protocol-specified exclusion criteria may apply.

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Refractive Error
• Refractive Errors

Intervention

Device:
• Wavelight® Refractive Suite
Excimer EX500 and Femtosecond FS200 lasers (Wavelight® Refractive Suite) used during LASIK surgery for corneal flap creation and corneal ablation

Procedure:
• LASIK surgery
Surgical procedure for treating refractive error based on corneal reshaping

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Alcon Research

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Least Squares Mean Difference in Binocular UCVA at 1 Month Post-Treatment and Pre-Treatment Binocular BCVA	Visual acuity (VA) with corrective devices (BCVA) was assessed binocularly (both eyes together) pre-treatment and subtracted from VA without spectacles or other visual corrective devices (UCVA) assessed binocularly at 1 month post-treatment. VA was measured at a distance of 4 meters and reported in logMAR (logarithm of the minimum angle of resolution), with 0.00 logMAR corresponding to 20/20 Snellen. A negative value indicates an improvement in VA from pre-treatment to Month 1.	Month 1	No
Secondary	Mean Difference Between Achieved and Target Corneal Flap Thickness as Assessed by OCT	The expected flap thickness as determined pre-operatively was subtracted from the achieved flap thickness as assessed by optical coherence tomography (OCT) (ie, an imaging method using light to capture three-dimensional images). A positive number represents a postoperative flap thickness that is thicker than the expected flap thickness and vice versa for a negative number.	Operation/Surgery (Day 1), Month 1 Postoperative, Month 6 Postoperative	No
Secondary	Mean Manifest Refraction (Sphere)	Manifest refraction was performed under photopic lighting conditions using an Early Treatment Diabetic Retinopathy Study (ETDRS) chart at 4 meters. The subject was manually refracted to his/her best correction using a phoropter. Each eye individually contributed to the mean.	Baseline (Day 0), Operation/Surgery (Day 1), Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative	No
Secondary	Mean Manifest Refraction (Cylinder)	Manifest refraction was performed under photopic lighting conditions using an ETDRS chart at 4 meters. The subject was manually refracted to his/her best correction using a phoropter. Each eye individually contributed to the mean.	Baseline (Day 0), Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative	No
Secondary	Mean Laser Treatment Time	Treatment time with Excimer EX500 and Femtosecond FS200 lasers, measured in seconds.	Day 0 (surgery)	No
Secondary	Mean Total Laser Treatment Time	Total treatment time with Excimer EX500 and Femtosecond FS200 lasers, measured in seconds. Total duration for both eyes was calculated as sum of duration for the right eye and left eye.	Day 0 (surgery)	No
Secondary	Mean Response: "Rate Your Vision, Over the Past 4 Weeks, With NO Glasses or Contact Lenses"	As recorded by the subject on the the Refractive Status and Vision Profile (RSVP), a self-reported questionnaire used to measure vision-related health status in persons with refractive error, on a scale from 0 (completely blind) to 10 (perfect vision).	Baseline (Day 0), Month 1 Postoperative, Month 6 Postoperative	No
Secondary	Percent Response by Category: "In the Past 4 Weeks, to See Far Away, I Wore..."	As recorded by the subject on the RSVP questionnaire, where n/a means no use of glasses or contact lenses.	Baseline (Day 0), Month 1 Postoperative, Month 6 Postoperative	No
Secondary	Percent Response by Category: "I Worry About my Vision"	As recorded by the subject on the RSVP questionnaire	Baseline (Day 0), Month 1 Postoperative, Month 6 Postoperative	No
Secondary	Percent Response by Category: "My Vision Is a Concern in My Daily Life"	As recorded by the subject on the RSVP questionnaire	Baseline (Day 0), Month 1 Postoperative, Month 6 Postoperative	No
Secondary	Percent Response by Category: "Driving at Night"	As recorded by the subject on the RSVP questionnaire, where 0 is "Not applicable", 1 is "No difficulty at all", 2 is "A little difficulty", 3 is "Moderate difficulty", 4 is "Severe difficulty" and 5 is "So much difficulty that I did not do the activity with this alternative".	Baseline (Day 0), Month 1 Postoperative, Month 6 Postoperative	No
Secondary	Mean Contrast Sensitivity (CS)	Contrast sensitivity (ie, the ability to detect slight changes in luminance before they become indistinguishable) was assessed binocularly with distance manifest correction in place and uncorrected. Contrast sensitivity was assessed at spatial frequencies of 3, 6, 12, and 18 cycles per degree (cpd), where 3.0 cpd = A, 6.0 cpd = B, 12.0 cpd = C, and 18.0 cpd = D. Raw scores were log transformed. A higher numeric value represents better contrast sensitivity.	Baseline (Day 0), Day 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative	No
Secondary	Wavefront Aberrometry	Wavefront aberrations (optical imperfections of the eye that prevent light from focusing perfectly on the retina, resulting in defects in the visual image) were measured using a commercially available system. Higher order aberrations (i.e., spherical aberrations, coma, and trifoil) are defined as optical imperfections which cannot be corrected by any reliable means of present technology.	Baseline (Day 0), Month 6 Postoperative	No
Secondary	Corneal Curvature as Measured by Keratometry	Corneal curvature was assessed by a commercially available system and measured in diopters.	Baseline (Day 0), Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative	No